Sign in

CIK 0000920148

  • Large accelerated filer

LABCORP HOLDINGS INC.

Sign in to watch
Ticker
LH
Exchange
NYSE
Industry
Services-Medical Laboratories
FY end
Dec 31
Entity type
Operating
EIN
992588107
Phone
+1 336-229-1127
Business address
358 S MAIN ST, BURLINGTON, NC, 27215
Former names
LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,377,699
in 4 filings, $108K under 10b5-1 plans

Net −$1,377,699. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-07 Kong Garheng Director Exercise or conversion +947 11,898
2024-02-07 Kong Garheng Director Exercise or conversion · Restricted Stock Unit −947 944
2024-02-07 Kliphouse Kirsten Marie Director Exercise or conversion +947 1,319
2024-02-07 Kliphouse Kirsten Marie Director Exercise or conversion · Restricted Stock Unit −947 944
2024-02-07 Gilliland Dwight Gary Director Exercise or conversion +947 8,712
2024-02-07 Gilliland Dwight Gary Director Exercise or conversion · Restricted Stock Unit −947 944
2024-02-07 Davis Jeffrey A. Director Exercise or conversion +947 3,619
2024-02-07 Davis Jeffrey A. Director Exercise or conversion · Restricted Stock Unit −947 944
2024-02-07 BELINGARD JEAN-LUC Director Exercise or conversion +947 17,876
2024-02-07 BELINGARD JEAN-LUC Director Shares withheld for taxes −95 $223.71 $21K 17,781
2024-02-07 BELINGARD JEAN-LUC Director Exercise or conversion · Restricted Stock Unit −947 236
2024-02-07 ANDERSON KERRII B Director Exercise or conversion +947 16,222
2024-02-07 ANDERSON KERRII B Director Exercise or conversion · Restricted Stock Unit −947 944
2024-02-06 Schechter Adam H President & CEO Grant or award · Restricted Stock Unit +13,380 101,491
2024-02-06 Schechter Adam H President & CEO Grant or award · Non-qualified Stock Options +41,400 41,400
2024-02-06 EISENBERG GLENN A Chief Financial Officer, EVP Grant or award · Restricted Stock Unit +2,900 37,431
2024-02-06 EISENBERG GLENN A Chief Financial Officer, EVP Grant or award · Non-qualified Stock Options +9,000 9,000
2024-02-06 DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl Grant or award · Restricted Stock Unit +980 5,540
2024-02-06 DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl Grant or award · Non-qualified Stock Options +3,000 3,000
2024-02-06 Caveney Brian J EVP, Pres of ED, CMO & CSO Grant or award · Restricted Stock Unit +2,010 16,397

Page 32 of 41 · 816 trades